Blog Archives

Great Lakes NeuroTechnologies Awarded Two New Patents for Movement Disorders Therapy Adjustment

VIEW PDF 15 OCT 2018: Independence, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it has been awarded two new U.S. Patents. The new patents include 10,085,689 (Device and method for monitoring and assessment of movement disorder symptoms) issued

The impact of a wearable device on Parkinson’s disease motor symptom management in patients starting rotigotine transdermal patch

S. Isaacson, B. Boroojerdi, K. Klos, S. Carson, M. Markowitz, D. Heldman, M. Phillips, D. Terricabras, F. Woltering, D. Truong. Movement Disorders Society Annual Meeting, 2018, Hong Kong.

Great Lakes NeuroTechnologies Receives Two New NIH SBIR Grant Awards

VIEW PDF 1 OCT 2018: Independence, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it has been awarded two new Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH), which will provide nearly $2 Million

Using Objective Measurement Via Wearable Sensors To Evaluate Real-world Effectiveness Of Carbidopa/Levodopa Enteral Suspension For Managing Motor Fluctuations: PROviDE Study Design And Baseline Characteristics

R. Pahwa, R. Dorsey, I. Pan, S. van Norman, T. Marshall, D. Heldman, Y. Jalundhwala. 70th Annual Meeting of the American Academy of Neurology, Los Angeles, CA, 2018

Wearable Motion Quantification and Electronic Diaries for Long-Term Monitoring of Parkinson’s Disease

A. Hadley, E. Urrea-Mendoza, N. Mennucci, C. Zimmerman, J. Giuffrida, Z. Mari, M. Burack, I. Itin, F. Revilla, D. Heldman. 70th Annual Meeting of the American Academy of Neurology, Los Angeles, CA, 2018

Great Lakes NeuroTechnologies Wins Patent on Using Cell Phones and Smart Watches to Help Treat Parkinson’s Disease

VIEW PDF 08 DEC 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) received another Notice of Allowance for a new patent covering the use of cell phones and watches to analyze movement disorders such as Parkinson’s disease. The new

App-Based Bradykinesia Tasks for Clinic and Home Assessment in Parkinson’s Disease: Reliability and Responsiveness

Heldman DA, Urrea-Mendoza E, Lovera LC, Schmerler DA, Garcia X, Mohammad ME, McFarlane MCU, Giuffrida JP, Espay AJ, Fernandez HH. J Parkinsons Dis. 2017;7(4):741-747.

Does Added Objective Tremor Monitoring Improve Clinical Outcomes in Essential Tremor Treatment?

Vittal P, Pulliam CL, Goetz CG, Ouyang B, Jankovic J, Ramirez-Castaneda JL, Heldman, DA. Mov Disord Clin Pract. 2018; 5: 96-98.

Great Lakes NeuroTechnologies Expands Patent Portfolio

VIEW PDF 12 SEPT 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) expanded its large patent portfolio covering deep brain stimulation (DBS) tuning to 11 issued patents (and 20 currently pending applications) when it was recently awarded Patent 9,717,920

Telehealth Management of Parkinson’s Disease Using Wearable Sensors: An Exploratory Study

Dustin A. Heldman; Denzil A. Harris; Timothy Felong; Kelly L. Andrzejewski; E. Ray Dorsey; Joseph P. Giuffrida; Barry Goldberg; Michelle A. Burack. Digit Biomark 2017;1:43–51